A prolactin-secreting tumor in a patient with Klinefelter's syndrome: A case report

Journal of Endocrinological Investigation

Volumn 19, Issue 4, 1996, Pages 248-252

  Pinto, A C A R ^a   Czepielewski, M A ^a,b   Gross, J L ^a   Mussio, W ^a,b   Lengyel, A M J ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Estrogen; Hypogonadism; Klinefelter's syndrome; Prolactmoma; Testosterone; Tumor formation

Indexed keywords

PROLACTIN; TESTOSTERONE;

ADENOMA; ADULT; ARTICLE; CASE REPORT; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; KLINEFELTER SYNDROME; MALE; PATHOPHYSIOLOGY; SECRETION;

ADENOMA; ADULT; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; KLINEFELTER SYNDROME; MALE; PROLACTIN; TESTOSTERONE;

EID: 0030115404     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349876     Document Type: Article

References (43)

1. Mukerjee D., Bowen J., Anderson D.E. Simian Papovavirus 40 transformation of cells from cancer patient with XY/XXY mosaic Klinefelter's syndrome. Cancer Res. 30:1769, 1970.
2. Scheike O., Visfeldt J., Petersen B. Male breast cancer. Acta Path. Microbiol. 87:352, 1973.
3. Pascual J., Liano F., Garcia-Villanueva A., Salvador J.L., Herrero J.A., Ortuno J. Isolated primary aldosteronism in patient with adrenal carcinoma and XY/XXY mosaic Klinefelter's syndrome. J. Urol. 144:1454, 1990.
4. Carroll P.R., Morse M.J., Koduro P.P.K., Chaganti R.S.K. Testicular germ cell tumor in patient with Klinefelter's syndrome. Urology 37. 72, 1988.
5. Lee M.W., Stephens R.L. Klinefelter's syndrome and extragonadal germ cell tumors. Cancer 60: 1053, 1987.
6. Konig R., Schonberger W., Grimm W. Mediastinales terato-carzinom und hypophysenstielgerminom bei einem patienten mit Klinefelter syndrom. Klin. Pediatr. 202:53, 1990.
7. Gohji K., Goto A., Takenaka A., Arakawa S., Matumoto D., Hikosaka K., Kamidomo S. Extragonadal germ cell tumor in the retrovesical region associated with Klinefelter's syndrome: a case report and review of literature. J. Urol. 747:133, 1989.
8. Schwartz D., Root A.W. The Klinefelter syndrome of testicular dysgenesis. Endocrinol. Metab. Clin. North Am. 20: 153, 1991.
9. Mamunes P., Lapidus P.H., Abbot J.A., Roath S. Acute leukaemia and Klinefelter's syndrome. Lancet 2: 26, 1961.
10. Liang R., Woo E., Ho F., Collins R., Choy D., Ma J. Klinefelter's syndrome and primary central nervous system lymphoma. Med. Pediatr. Oncol. 18: 236, 1990.
11. Kleczkowska A., Fryns J.P., Van den Berghe H. X-chromosome polysome in male. Hum. Genet. 80: 16, 1988.
12. Arduino L.J., Glucksman M.A. Interstitial cell tumor of the testis associated with Klinefelter's syndrome: a case report. J. Ural. 89: 246, 1963.
13. Fujita K., Fujita H.M. Klinefelter's syndrome and bladder cancer. J. Urol. 116:836, 1976.
14. Beuers U., Richter W.O., Ritter M.M.. Wiebecke B., Schwandt P. Klinefelter's syndrome and liver adenoma. J. Clin. Gastroenterol. 73:214, 1991.
15. Nakano Y., Sato A., Iwata M., Okano A., Hayakawa H., Chida K., Honda K. A case of Klinefelter's syndrome associated with lung cancer and RA lung. Nippon Kyobu Shikkan Gakkai Zasshi 29:495, 1991.
16. Pienkos E.J., Meisner R.F. Adenocarcinoma of the prostate in a 41-year-old man with XXY karyotype and chronic lymphocytic leukemia: report of a case. J. Urol. 745:148, 1991.
17. Grossman A., Besser G.M. Prolactinomas. Br. Med. J. 290:182, 1985.
18. Lengyel A.M.J., Mussio W., Imamura P., Vieira J.G.H., Lancranjan I. Long-acting injectable bromocriptine (Parlodel LAP) in the chronic treatment of prolactin-secreting macroadenoma. Fertil. Steril. 59:980, 1993.
19. Moult P.J.A., Rees L.H., Besser G.M. Pulsatile gonadotrophin secretion in hyperprolactinemic amenorrhoea and the response to bromocriptine therapy. Clin. Endocrinol. (Oxf) 16:153, 1982.
20. Carter J.N., Tyson M.D., Tous G., Vliet V.S., Faiman C., Friesen H.G. Prolactin-secreting tumors and hypogonadism in 22 men. N. Engl. J. Med. 299:847, 1978.
21. Buvat J., Lemaire A., Buvat-Herbaut M., Fourlinne J.C, Racadot A., Fossat P. Hyperprolactinemia and sexual function in men. Norm. Res. 22:196, 1985.
22. Nielsen J., Wohlert M. Sex chromosome abnormalities found among 34910 newborn children: results from a 13-year incidence study in Arthus, Denmark. Birth Defects 26:209, 1990.
23. Magrini G., Ebiner J.R., Burckhardt P., Felber J.P. Study on the relationship between plasma prolactin levels and androgen metabolism in man. J. Clin. Endocrinol. Metab. 43:944, 1976.
24. Rittmaster R.S. Finasteride. N. Engl. J. Med. 330: 120, 1994.
25. Sharpe R.M., Mc Neilly A.S. The effect of induced hyperprolactinaemia on leydig cell function and LH-induced loss of LH-receptor in the rat testis. Mol. Cell. Endocrinol. 16: 19, 1979.
26. Burrow G.N., Wortzman G., Rewcastle N.B., Holgate R., Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N. Engl. J. Med. 15: 156, 1981.
27. Prior J.C., Cox I.A., Fairholm D., Kostashuk E.. Nugent R. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J. Clin. Endocrinol. Metab. 64:391, 1987.
28. Franks S. Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin. Sei. 65:457, 1983.
29. Gooren L.J.C., Assies J., Asscheman H., de Slegte R., van Kessel H. Estrogen-induced prolactinoma in a man. J. Clin. Endocrinol. Metab. 66:444, 1988.
30. Wiklund U.A., Gorski J. Genetic differences in estrogen-induced deoxyribonucleic acid synthesis in the rat pituitary: correlations with pituitary tumor susceptibility. Endocrinology 111:1140, 1982.
31. Bevan U.S., Sussman J., Roberts A. Hourihan M., Peters J.R. Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case Report. Br. J. Obstet. Gynecol. 96: 1440, 1989.
32. Garcia M.M., Kapcala L.P. Growth of a microprolactinoma to a macroproiactinoma during estrogen therapy. J. Endocrinol. Invest. 18:450, 1995.
33. Stefaneau L., Kovacs K. Immunocytochemistry approach to demonstrate the estrogen receptor in human adenohypophyses and pituitary adenomas with monoclonal antibody. Med. Sci. Res. 76:449, 1988.
34. Stefaneanu L., Kovacs K., Horvath E., Lloyd V., Buchfelder M., Fahlbusch R., Smyth H. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J. Clin. Endocrinol. Metab. 78:83, 1994.
35. Thapar K., Kovacs K., Laws E.R., Muller P.J. Pituitary adenomas: current concepts in classification, histopathology, and molecular biology. The Endocrinologist 3:39, 1993.
36. Borgundvaag B., Kudlow J.E., Mueller S.C., George S.R. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-a gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130: 3453. 1992.
37. Sirbasku D.A. Estrogen induction of growth factors specific for hormone responsive mammary, pituitary and kidney tumor cells. Proc. Natl. Acad. Sci USA. 75:3786, 1978.
38. Me Andrew J., Paterson A.J.. Asa S., Kudlow E. Transforming growth factor-oc overexpression in the pituitary of transgenic mice. 76th Annual Meeting of Endocrine Society, Anaheim 1994. abstract 25, p. 207 (Abstract).
39. 4 pituitary tumor cell proliferation. Endocrinology 128: 1981, 1991.
40. 1 like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133:1444, 1993.
41. Salbenblatt J.A.. Bender B.G., Puck M.H., Robinson A., FaimanC., Winter J.S.D. Pituitary-gonadal function in Klinefelter's syndrome before and during puberty. Pediatr. Res. 19: 82, 1985.
42. Sharma M.K.G., Balasinor N.L., Juneja H.S. Modulation of pituitary gonadotropins and prolactin secretion by testosterone in vitro. J. Endocrinol. Invest. 75:549, 1992.
43. Cheikh I.E., Hamilton B.P.M., Hsu T.H., Wiswell J.G. Studies using releasing factors in Klinefelter's syndrome: The responses of LH and FSH to luteinizing hormone-releasing hormone and prolactin and TSH to thyrotropin-releasing hormone before and after testosterone. Psychoneuroendocrinology 6:37, 1981.